ESOC 2025 - Visit the EVER Pharma Symposium

EVER Pharma will present new data from 3 new studies during the symposium on ESOC 2025 in Helsinki, Finland. Join this event!

Cerebroprotective Treatment Strategies in Stroke
Evidence from 3 new studies

Wednesday, 21 May 2025, 13:15 - 14:15, Hall 3c

Chair: Andrei Alexandrov (USA)

• Cerebroprotection as an Adjunct to Mechanical Thrombectomy
  WIM Study Results
  Jacek Staszewski (Poland)
• Can we identify the optimal patient population that benefits most from cerebroprotective treatment?
  Promising results in AIS and rehabilitation studies
  Michael Brainin (Austria)

Visit our EVER Satellite Symposium and you will receive a quick guide to important rating scales regarding stroke assessment, stroke treatment and stroke rehabilitation outcome.

Please find all information to ESOC 2025 here!